Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Simulations Plus Inc SLP

Healthcare Medical Devices
Simulations Plus, Inc. is a provider of modeling and simulation software and services for pharmaceutical drug discovery and development, including the prediction of properties of molecules utilizing both artificial intelligence and machine-based technology. The Company's segments include software and services. It offers 12 software products for pharmaceutical research and development... see more

Recent & Breaking News (NDAQ:SLP)

Simulations Plus Expands Marketing and Sales Operations in South America Through Partnership with the Institute of Pharmaceutical Sciences

Business Wire January 26, 2021

Simulations Plus Awards Infrastructure Improvement Grant to Makerere University Department of Pharmacology and Therapeutics

Business Wire January 14, 2021

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Simulations Plus, Inc. - SLP

Newsfile January 12, 2021

Simulations Plus to Present at 23rd Annual Needham Virtual Growth Conference

Business Wire January 12, 2021

Simulations Plus Enters New Funded Collaboration to Improve Lung Exposure Models for Pulmonary Infection Treatments

Business Wire January 12, 2021

Simulations Plus Reports Record First Quarter FY2021 Financial Results

Business Wire January 11, 2021

Simulations Plus Enters New Funded Collaboration to Enhance Top-Rated GastroPlus® ACAT(TM) Model for Oral Absorption of Peptides

Business Wire January 5, 2021

Simulations Plus Sets Date for First Quarter Fiscal Year 2021 Earnings Release and Conference Call

Business Wire January 4, 2021

Simulations Plus Publishes its Inaugural Environmental, Social and Governance (ESG) Report

Business Wire December 16, 2020

DILIsym Services Presents Important DILIsym and NAFLDsym Software Applications at the Virtual AASLD Liver Meeting

Business Wire December 3, 2020

Simulations Plus Names Industry Veteran Will Frederick as Chief Financial Officer

Business Wire December 1, 2020

Simulations Plus Reports FY2020 and Fourth Quarter FY2020 Financial Results

Business Wire November 16, 2020

DILIsym Plays Critical Role in Submission to State of California for Common Analgesic Carcinogenicity Risk Assessment

Business Wire November 10, 2020

Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2020 Earnings Release and Conference Call

Business Wire November 9, 2020

Simulations Plus to Participate in the Credit Suisse Virtual Healthcare Conference

Business Wire November 5, 2020

Lixoft Expands MonolixSuite(TM) in Version 2020R1

Business Wire November 3, 2020

First Approved Cancer Treatment for TGCT Included DILIsym Simulations in FDA Review

Business Wire October 27, 2020

Simulations Plus Releases GastroPlus® Version 9.8

Business Wire October 20, 2020

Simulations Plus Teams Up with the University of Health Sciences and Pharmacy in St. Louis to Secure New Grant Award from the U.S. FDA

Business Wire October 13, 2020

Simulations Plus Announces Quarterly Cash Dividend of $0.06 per Share

Business Wire October 13, 2020